Evidence map›Paper›PMID 42621560›Full record

ArticleInternational journal of preventive medicine2026

Benefit of Psyllium with Weight Loss Diet in Preventing Liver Dysfunction in Overweight or Obese Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Zahra Akbarzadeh, Mojgan Nourian, Gholamreza Askari, Mohammad R Maracy, Reza Amani

Abstract read
In one paragraph

Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zahra AkbarzadehDepartment of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Mojgan NourianDepartment of Community Nutrition, Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Gholamreza AskariDepartment of Community Nutrition, Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad R MaracyDepartment of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Reza AmaniDepartment of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: MASLD is the revised nomenclature of nonalcoholic fatty liver disease (NAFLD) which is the most common chronic liver disease worldwide and it significantly impacts the burden of the disease. Individuals who are overweight or obese have three times higher risk of developing MASLD. Losing body weight is, therefore, recommended to manage MASLD. This study was performed to assess the effect of psyllium on liver function in overweight or obese adults with (MASLD). Methods: We assessed 80 overweight or obese MASLD patients diagnosed by elastography. They were divided into intervention and placebo groups through randomized block design. Intervention group was given 10 grams of psyllium and the control group was given 10 grams of ground wheat as supplement. Weight loss diet and physical activity (PA) recommendations were followed by both groups for 10 weeks. Serum liver enzymes, liver function (measured by fibroscan), PA, and dietary intake were assessed pre- and post-intervention. Results: Totally, 78 participants finished the RCT. After controlling confounding variables, intake of calorie ( Conclusions: Psyllium can be introduced as a dietary supplement that exerts beneficial role in gut health, weight loss, and preventing MASLD.

Indexed as

Dietary intakefiberliver functionnon-alcoholic fatty liver diseaseobesitypsyllium

Identifiers

PMID42621560
PMCPMC13489564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.